Defiance Daily Target 2X Long LLY ETF (LLYX) Price & Chart
LLYX ETF Chart & Stats
- Day’s Range
- $28.75 - $30.07
- 52-Week Range
- $14.55 - $31.28
- Previous Close
- $29.28
- Volume
- 150.02K
- Average Volume (3M)
- 296.57K
- AUM
- 81.46M
- NAV
- 29.35
- Expense Ratio
- 1.49%
- Holdings Count
- 0
- Beta
- 0.85
- Inception Date
- Aug 07, 2024
- Last Dividend Ex-Date
- Dec 30, 2025
- Dividend Yield
- (2.40%)
- Shares Outstanding
- 1,395,000
- Standard Deviation
- N/A
ETF Overview
Defiance Daily Target 2X Long LLY ETF
The Defiance Daily Target 2X Long LLY ETF, with the ticker symbol LLYX, is a cutting-edge financial instrument tailored for investors looking to capitalize on the dynamic health care sector, specifically within the pharmaceuticals niche. This ETF is designed to offer twice the daily performance of its underlying index, making it an ideal choice for sophisticated investors seeking amplified exposure to the pharmaceutical market. By focusing on a sector known for its innovation and resilience, LLYX provides an opportunity to benefit from the growth and advancements in drug development, biotechnology, and healthcare solutions. With its strategic leverage, this ETF caters to those with a high-risk appetite, aiming to maximize gains from short-term market movements within the pharmaceutical industry. Whether you're looking to hedge other investments or pursue aggressive growth, the Defiance Daily Target 2X Long LLY ETF offers a unique and potent investment vehicle in the ever-evolving world of healthcare.